The effects of finasteride on hematuria associated with benign prostatic hyperplasia: a preliminary report.
The efficacy of finasteride was assessed in the treatment of gross hematuria associated with benign prostatic hyperplasia (BPH). A retrospective review was done of 18 patients who had been placed on finasteride (5 mg . daily) for the treatment of gross hematuria associated with BPH. A hematuria grading system was devised. Of the 12 patients with longer than 3 months of followup (mean 14) 11 improved according to the grade of hematuria after finasteride therapy. Finasteride is effective in treating hematuria associated with BPH. This finding is especially relevant for patients with multiple medical problems and anesthetic risks.